Cargando…

Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis

Inconsistency between reported findings on the association of prostate specific antigen (PSA) gene -158G/A polymorphism with benign prostatic hyperplasia (BPH) susceptibility need a meta-analysis to obtain a more accurate conclusion. A systematic search was conducted in electronic databases for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Xin-Jun, Zeng, Xian-Tao, Fang, Cheng, Liu, Tong-Zu, Wang, Xing-Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464925/ https://www.ncbi.nlm.nih.gov/pubmed/28430620 http://dx.doi.org/10.18632/oncotarget.15424

Ejemplares similares

Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis
por: Zeng, Xian-Tao, et al.
Publicado: (2017)

Association between Diabetes Mellitus and Hypertension in Benign Prostatic Hyperplasia Patients
por: Zeng, Xian-Tao, et al.
Publicado: (2018)

Role of CYP17 rs743572 Polymorphism in Benign Prostatic Hyperplasia: A Multivariate Integrated Analysis
por: Weng, Hong, et al.
Publicado: (2019)

The Significance of PSA/IGF-1 Ratio in Differentiating Benign Prostate Hyperplasia from Prostate Cancer
por: Koliakos, G., et al.
Publicado: (2000)

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
por: Gudmundsson, Julius, et al.
Publicado: (2018)

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients
por: Zeng, Xian-Tao, et al.
Publicado: (2018)

Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia
por: Jia, Gaozhen, et al.
Publicado: (2017)

Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients
por: Zi, Hao, et al.
Publicado: (2019)

Plasmakinetic resection technology for the treatment of benign prostatic hyperplasia: evidence from a systematic review and meta-analysis
por: Li, Sheng, et al.
Publicado: (2015)

Holmium Laser Enucleation versus Transurethral Resection in Patients with Benign Prostate Hyperplasia: An Updated Systematic Review with Meta-Analysis and Trial Sequential Analysis
por: Li, Sheng, et al.
Publicado: (2014)

Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity
por: Stephan, Carsten, et al.
Publicado: (2008)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation
por: Fang, Cheng, et al.
Publicado: (2021)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study
por: Logozzi, Mariantonia, et al.
Publicado: (2019)

Genetic Association between Matrix Metalloproteinases Gene Polymorphisms and Risk of Prostate Cancer: A Meta-Analysis
por: Weng, Hong, et al.
Publicado: (2017)

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)
por: Zeng, Xian-Tao, et al.
Publicado: (2022)

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications
por: Fang, Cheng, et al.
Publicado: (2017)

The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
por: Huskova, Zlata, et al.
Publicado: (2020)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Genetic alterations in benign prostatic hyperplasia patients
por: Mohamed, Hanaa Mahmoud, et al.
Publicado: (2017)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Variation of Serum PSA Levels in COVID-19 Infected Male Patients with Benign Prostatic Hyperplasia (BPH): A Prospective Cohort Studys
por: Cinislioglu, Ahmet Emre, et al.
Publicado: (2022)

Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis
por: Sadeghiyeh, Tahereh, et al.
Publicado: (2017)

Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study
por: Wu, Lan, et al.
Publicado: (2019)

Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia
por: Leidinger, Petra, et al.
Publicado: (2015)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats
por: Li, Lu-Yao, et al.
Publicado: (2022)

Association of catechol-o-methyl transferase gene polymorphism with prostate cancer and benign prostatic hyperplasia
por: Omrani, Mir Davood, et al.
Publicado: (2009)

Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019)

Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis
por: Zhang, Lei, et al.
Publicado: (2020)

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
por: Tong, Yu, et al.
Publicado: (2020)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
por: Xing, Nianzeng, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ec8t6puhieujklro0da1i1945c